Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC
Clinical trial NCT03897946 · COMPLETED
Trial details
- NCT number
- NCT03897946
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-20
- Primary completion
- 2021-02-05
- Enrollment
- 569
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.